Plasma membrane calcium ATPases as novel candidates for therapeutic agent development

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 16, Issue 2, 2013, Pages 190-206

  Strehler, Emanuel E ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALMIDAZOLIUM; CALMODULIN INHIBITOR; DIGOXIN; EOSIN; FLUORESCEIN DERIVATIVE; ISOENZYME; LANTHANUM; ORTHOVANADIC ACID; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TRIFLUOPERAZINE;

ARTICLE; BONE DISEASE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CEREBELLAR ATAXIA; DOWN REGULATION; DRUG BINDING SITE; DRUG DESIGN; DRUG TARGETING; ENZYME LOCALIZATION; ENZYME STRUCTURE; GENE; GENE DELETION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HEARING IMPAIRMENT; HIGH THROUGHPUT SCREENING; HUMAN; HYPERTENSION; MALE INFERTILITY; MUTATIONAL ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PMCA1 GENE; PMCA2 GENE; PMCA4 GENE; PROTEIN SYNTHESIS INHIBITION;

EID: 84877990386     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3z011     Document Type: Article

References (138)

1. Pedersen PL, Carafoli E. (1987) Ion motive ATPases. I. Ubiquity, properties, and significance to cell function. Trends Biochem. Sci., 12, 146-150.
2. Moeller JV, Juul B, Le Maire M. (1996) Structural organization, ion transport, and energy transduction of P-type ATPases. Biochim. Biophys. Acta, 1286, 1-51.
3. Palmgren MG, Nissen P. (2011) P-type ATPases. Ann. Rev. Biophys., 40, 243-266.
4. Axelsen KB, Palmgren MG. (1998) Evolution of substrate specificities in the P-type ATPase superfamily. J. Mol. Evol., 46, 84-101.
5. Thever MD, Saier MH. (2009) Bioinformatic characterization of P-type ATPases encoded within the fully sequenced genomes of 26 eukaryotes. J. Membr. Biol., 229, 115-130.
6. Strehler EE, Zacharias DA. (2001) Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol. Rev., 81, 21-50.
7. Brini M, Carafoli E. (2009) Calcium pumps in health and disease. Physiol. Rev., 89, 1341-1378.
8. Monteith GR, Roufogalis BD. (1995) The plasma membrane calcium pump - a physiological perspective on its regulation. Cell Calcium, 18, 459-470.
9. 2+ pump. J. Membr. Biol., 165, 101-109.
10. Strehler EE, Treiman M. (2004) Calcium pumps of plasma membrane and cell interior. Curr. Mol. Med., 4, 323-335.
11. 2+ ATPase of animal cells: Structure, function and regulation. Arch. Biochem. Biophys., 476, 65-74.
12. Schatzmann HJ. (1982) The plasma membrane calcium pump of erythrocytes and other animal cells. In: Membrane Transport of Calcium (ed. E Carafoli). Academic Press, London.
13. Carafoli E. (1991) Calcium pump of the plasma membrane. Physiol. Rev., 71, 129-153.
14. Brandt P, Neve RL, Kammesheidt A, Rhoads RE, Vanaman TC. (1992) Analysis of the tissue-specific distribution of mRNAs encoding the plasma membrane calcium-pumping ATPases and characterization of an alternately spliced form of PMCA4 at the cDNA and genomic levels. J. Biol. Chem., 267, 4367-4385.
15. 2+-ATPase isoforms 1,2,3, and 4. J. Biol. Chem., 268, 2740-2748.
16. Stauffer TP, Hilfiker H, Carafoli E, Strehler EE. (1993) Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes [published erratum appears in J. Biol. Chem. 269:32022 (1994)]. J. Biol. Chem., 268, 25993-26003.
17. 2+ pump. A study using specific antibodies. J. Biol. Chem., 270, 12184-12190.
18. Zacharias DA, Kappen C. (1999) Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. Biochim. Biophys. Acta, 1428, 397-405.
19. Brandt P, Neve RL. (1992) Expression of plasma membrane calcium-pumping ATPase mRNAs in developing rat brain and adult brain subregions: Evidence for stage-specific expression. J. Neurochem., 59, 1566-1569.
20. 2+-ATPase isoform PMCA1c is associated with cell fusion in C2 myocytes. J. Neurochem., 62, 799-802.
21. Kenyon KA, Bushong EA, Mauer AS, Strehler EE, Weinberg RJ, Burette AC. (2010) Cellular and subcellular localizatin of the neuron-specific plasma membrane calcium ATPase PMCA1a in the rat brain. J. Comp. Neurol., 518, 3169-3183.
22. 2+-ATPase isoforms: distribution of mRNAs in rat brain by in situ hybridization. Molec. Brain Res., 16, 223-231.
23. 2+ ATPase in the rat brain. J. Comp. Neurol., 467, 464-476.
24. 2+ ATPases as dynamic regulators of cellular calcium handling. Ann. N. Y. Acad. Sci., 1099, 226-236.
25. Krizaj D, DeMarco SJ, Johnson J, Strehler EE, Copenhagen DR. (2002) Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. J. Comp. Neurol., 451, 1-21.
26. 2+ ATPase isoform 2a is the PMCA of hair bundles. J. Neurosci., 21, 5066-5078.
27. 2+ pump is slow and is changed by alternative splicing. J. Biol. Chem., 274, 35227-35232.
28. Caride AJ, Penheiter AR, Filoteo AG, Bajzer Z, Enyedi Á, Penniston JT. (2001) The plasma membrane calcium pump displays memory of past calcium spikes. Differences between isoforms 2b and 4b. J. Biol. Chem., 276, 39797-39804.
29. 2+ pump isoform 4a differs from isoform 4b in the mechanism of calmodulin binding and activation kinetics. J. Biol. Chem., 282, 25640-25648.
30. 2+ pump is controlled by alternative splicing. J. Biol. Chem., 269, 41-43.
31. Garside ML, Turner PR, Austen B, Strehler EE, Beesley PW, Empson RM. (2009) Molecular interactions of the plasma membrane calcium ATPase 2 at pre-and post-synaptic sites in rat cerebellum. Neuroscience, 162, 383-395.
32. Oceandy D, Mohamed TMA, Cartwright EJ, Neyses L. (2011) Local signals with global impacts and clinical implications: Lessons from the plasma membrane calcium pump (PMCA4). Biochim. Biophys. Acta, 1813, 974-978.
33. 2+ ATPase isoform 4b binds to membraneassociated guanylate kinase (MAGUK) proteins via their PDZ (PSD-95/Dlg/ZO-1) domains. J. Biol. Chem., 273, 1591-1595.
34. 2+-ATPase isoforms 2b and 4b interact promiscuously and selectively with members of the membrane-associated guanylate kinase family of PDZ (PSD-95/Dlg/ZO-1) domain-containing proteins. J. Biol. Chem., 276, 21594-21600.
35. 2+/calmodulin-dependent membrane-associated kinase CASK. J. Biol. Chem., 278, 9778-9883.
36. Bozulic LD, Malik MT, Powell DW, Nanez A, Link AJ, Ramos KS, Dean WL. (2007) Plasma membrane Ca(2+)-ATPase associates with CLP36, alphaactinin and actin in human platelets. Thromb. Haemost., 97, 587-597.
37. + exchanger regulatory factor 2 in apical plasma membranes. J. Biol. Chem., 277, 10506-10511.
38. 2+-ATPase b-splice variants. Ann. N. Y. Acad. Sci., 986, 461-471.
39. Schuh K, Uldrijan S, Telkamp M, Röthlein N, Neyses L. (2001) The plasmamembrane calmodulindependent calcium pump: a major regulator of nitric oxide synthase I. J. Cell Biol., 155, 201-205.
40. Sgambato-Faure V, Xiong Y, Berke JD, Hyman SE, Strehler EE. (2006) The homer-1 protein Ania-3 interacts with the plasma membrane calcium pump. Biochem. Biophys. Res. Commun., 343, 630-637.
41. 2+-ATPase pump. J. Biol. Chem., 280, 37195-37203.
42. 2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1). J. Biol. Chem., 279, 31318-31328.
43. Buch MH, Pickard A, Rodriguez A, Gillies S, Maass AH, Emerson M, Cartwright EJ, Williams JC, Oceandy D, Redondo JM, Neyses L, Armesilla AL. (2005) The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit. J. Biol. Chem., 280, 29479-29487.
44. Williams JC, Armesilla AL, Mohamed TMA, Hagarty CL, McIntyre FH, Schomburg S, Zaki AO, Oceandy D, Cartwright EJ, Buch MH, Emerson M, Neyses L. (2006) The sarcolemmal calcium pump, a-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex. J. Biol. Chem., 281, 23341-23348.
45. 2+-ATPase: Regulation by PSD-95/Dlg/Zo-1 scaffolds. Int. J. Biochem. Cell Biol., 42, 805-808.
46. 2+ pump 2b variants in polarized epithelial cells. J. Biol. Chem., 285, 31704-31712.
47. Gómez-Varela D, Schnidt M, Schoellerman J, Peters EC, Berg DK. (2012) PMCA2 via PSD-95 controls calcium signaling by a7-containing nicotinic acetylcholine receptors on aspiny interneurons. J. Neurosci., 32, 6894-6905.
48. 2+ clearance during T-cell activation. EMBO J., 31, 1123-1133.
49. 2+)-ATPase of the erythrocyte membrane: reconstitution and effect of calmodulin and phospholipids. J. Biol. Chem., 256, 395-401.
50. 2+-ATPase. J. Biol. Chem., 256, 8588-8592.
51. Enyedi A, Flura M, Sarkadi B, Gardos G, Carafoli E. (1987) The maximum velocity and the calcium affinity of the red cell calcium pump may be regulated independently. J. Biol. Chem., 262, 6425-6430.
52. Carafoli E. (1994) Biogenesis: Plasma membrane calcium ATPase: 15 years of work on the purified enzyme. FASEB J., 8, 993-1002.
53. Strehler EE, James P, Fischer R, Heim R, Vorherr T, Filoteo AG, Penniston JT, Carafoli E. (1990) Peptide sequence analysis and molecular cloning reveal two calcium pump isoforms in the human erythrocyte membrane. J. Bio. Chem., 265, 2835-2842.
54. 2+ pump in COS-1 cells. Biochem. J., 285, 791-797.
55. 2+ pump involved in the activation. J. Biol. Chem., 282, 35440-35448.
56. 2+ pump and of its N-terminally truncated 105-kDa fragment. J. Bio. Chem., 267, 24476-24484.
57. 2+ ATPase. J. Biol. Chem., 269, 26178-26103.
58. 2+: fast pumps reside in fast cells. Cell Calcium, 30, 49-57.
59. Penheiter AR, Bajzer Z, Filoteo AG, Thorogate R, Török K, Caride AJ. (2003) A model for the activation of plasma membrane calcium pump isoform 4b by calmodulin. Biochemistry, 42, 12115-12124.
60. 2+ signalling. EMBO J., 19, 4926-4935.
61. 2+ pump isoforms in intact cells. J. Biol. Chem., 278, 24500-24508.
62. Antalffy G, Mauer AS, Pászty K, Hegedus L, Padányi R, Enyedi A, Strehler EE. (2012) Plasma membrane calcium pump (PMCA) isoform 4 is targeted to the apical membrane by the w-splice insert from PMCA2. Cell Calcium, 51, 171-178.
63. Curry MC, Luk NA, Kenny PA, Roberts-Thomson SJ, Monteith GR. (2012) Distinct regulation of cytoplasmic calcium signals and cell death pathways by different plasma membrane calcium ATPase isoforms in MDA-MB-231 breast cancer cells. J. Biol. Chem., 287, 28598-28608.
64. 2+-ATPase isoform 2. J. Biol. Chem., 273, 18693-18696.
65. 2+-ATPase (PMCA) 1 and 4 indicates a major housekeeping function for PMCA1 and a critical role in hyperactivated sperm motility and male fertility for PMCA4. J. Biol. Chem., 279, 33742-33750.
66. 2+ ATPase 4 is required for sperm motility and male fertility. J. Biol. Chem., 279, 28220-28226.
67. 2+-ATPase knockout mice. Ann. N. Y. Acad. Sci., 1099, 276-286.
68. 2+-ATPase in contraction-relaxation processes of the bladder: evidence from PMCA gene-ablated mice. Am. J. Physiol., 290, C1239-C1247.
69. 2+ homeostasis of bladder smooth muscle: evidence from PMCA gene-ablated mice. Am. J. Physiol., 292, C423-C431.
70. Kohara K, Tabara Y, J.N, Imai Y, Ohkubo T, Hata A, Soma M, Nakayama T, Umemura S, Hirawa N, Ueshima H, Kita Y, Igihara T, Katsuya T, Takahashi N, Tokunaga K, Miki T. (2008) Identification of hypertension-susceptibility genes and pathways by a systemic multiple candidate gene approach:the Millennium Genome Project for Hypertension. Hypertension Res., 31, 203-212.
71. The International Consortium for Blood Pressure Genome-Wide Association Studies. (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature, 478, 103-109.
72. Kobayashi Y, Hirawa N, Tabara Y, Muraoka H, Fujita M, Miyazaki N, Fujiwara A, Ichikawa Y, Yamamoto Y, Ichihara N, Saka S, Wakui H, Yoshida S, Yatsu K, Toya Y, Yasuda G, Kohara K, Kita Y, Takei K, Goshima Y, Ishikawa Y, Ueshima H, Miki T, Umemura S. (2012) Mice lacking hypertension candidate gene Atp2b1 in vascular smooth muscle cells show significant blood pressure elevation. Hypertension, 59, 854-860.
73. 2+-ATPase gene cause deafness in deafwaddler mice. Nature Genet., 19, 390-394.
74. 2+-ATPase gene causes deafness in Wriggle Mouse Sagami. Biochem. Biophys. Res. Commun., 261, 773-778.
75. Sun X, Chen Z, Hayashi Y, Kanou Y, Takagishi Y, Oda S, Murata Y. (2008) Insertion of an intracisternal A particle retrotransposon element in plasma membrane calcium ATPase 2 gene attenuates its expression and produces an ataxic phenotype in joggle mutant mice. Gene, 41, 94-102.
76. Spiden SL, Bortolozzi M, Di Leva F, de Angelis MH, Fuchs H, Lim D, Ortolano S, Ingham NJ, Brini M, Carafoli E, Mammano F, Steel KP. (2008) The novel mouse mutation oblivion inactivates the PMCA2 pump and causes progressive hearing loss. PLoS Genetics, 4, e1000238.
77. 2+ ATPase and deafness. Int. J. Biochem. Cell Biol., 44, 679-683.
78. 2+-ATPase isoform 2 impairs calcium transport into milk. J. Biol. Chem., 279, 42369-42373.
79. Kurnellas MP, Lee AK, Li H, Deng L, Ehrlich DJ, Elkabes S. (2007) Molecular alterations in the cerebellum of the plasma membrane calcium ATPase 2 (PMCA2)-null mouse indicate abnormalities in Purkinje neurons. Mol. Cell. Neurosci., 34, 178-188.
80. 2+ ATPase 2 contributes to short-term synapse plasticity at the parallel fibre to Purkinje neurone synapse. J. Neurosci., 27, 3753-3758.
81. 2+ dynamics in mouse cerebellar Purkinje neurones and alters the precision of motor coordination. J. Physiol., 588.6, 907-922.
82. 2+ ATPase to cerebellar synapse function. World J. Biol. Chem., 1, 95-102.
83. Schultz JM, Yang Y, Caride AJ, Filoteo AG, Penheiter AR, Lagziel A, Morell RJ, Mohiddin SA, Fananapazir L, Madeo AC, Penniston JT, Griffith AJ. (2005) Modification of human hearing loss by plasma-membrane calcium pump PMCA2. New England J. of Med., 352, 1557-1564.
84. Ficarella R, Di Leva F, Bortolozzi M, Ortolano S, Donaudy F, Petrillo M, Melchionda S, Lelli A, Domi T, Fedrizzi L, Lim D, Shull GE, Gasparini P, Brini M, Mammano F, Carafoli E. (2007) A functional study of plasma-membrane calcium-pump isoform 2 mutants causing digenic deafness. Proc. Nat. Acad. Sci. U.S.A., 104, 1516-1521.
85. 2+ homeostasis. Proc. Nat. Acad. Sci. U.S.A., 109, 14514-14519.
86. Burette A, Weinberg RJ. (2007) Perisynaptic organization of plasma membrane calcium pumps in cerebellar cortex. J. Comp. Neurol., 500, 1127-1135.
87. Cartwright EJ, Neyses L. (2010) Evaluation of plasma membrane calcium/calmodulin-dependent ATPase isoform 4 as a potential target for fertility control. Handb. Exp. Pharmacol., 198, 79-95.
88. Oceandy D, Mamas MA, Neyses L. (2007) Targeting the sarcolemmal calcium pump: a potential novel strategy for the treatment of cardiovascular disease. Cardiovasc. Hematol. Agents Med. Chem., 5, 300-304.
89. Oceandy D, Cartwright EJ, Emerson M, Prehar S, Baudoin FM, Zi M, Alatwi N, Venetucci L, Schuh K, Williams JC, Armesilla AL, L. N., (2007) Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b. Circulation, 115, 483-492.
90. Mohamed TMA, Oceandy D, Prehar S, Alatwi N, Hegab Z, Baudoin FM, Pickard A, Zaki AO, Nadif R, Cartwright EJ, Neyses L. (2009) Specific role of neuronal nitric-oxide synthase when tethered to the plasma membrane calcium pump in regulating the b-adrenergic signal in the myocardium. J. Biol. Chem., 284, 12091-12098.
91. Mohamed TMA, Oceandy D, Zi M, Prehar S, Alatwi N, Wang Y, Shaheen MA, Abou-Leisa R, Schelcher C, Hegab Z, Baudoin F, Emerson M, Mamas M, Di Benedetto G, Zaccolo M, Lei M, Cartwright EJ, Neyses L. (2011) Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomain. J. Biol. Chem., 286, 41520-41529.
92. 2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents. J. Clin. Invest., 119, 976-985.
93. Gros R, Afroze T, You X-M, Kabir G, Van Wert R, Kalair W, Hoque AE, Mungrue IN, Husain M. (2003) Plasma membrane calcium ATPase overexpression in arterial smooth muscle increases vasomotor responsiveness and blood pressure. Circ. Res., 93, 614-621.
94. Schuh K, Quaschning T, Knauer S, Hu K, Koçak S, Roethlein N, Neyses L. (2003) Regulation of vascular tone in animals overexpresing the sarcolemmal calcium pump. J. Biol. Chem., 278, 41246-41252.
95. Timmann C, Thye T, Vens M, Evans J, May J, Ehmen C, Sievertsen J, Muntau B, Ruge G, Loag W, Ansong D, Antwi S, Asafo-Adjei E, Nguah SB, Kwakye KO, Akoto AOY, Sylverken J, Brendel M, Schuldt K, Loley C, Franke A, Meyer CG, Agbenyega T, Ziegler A, Horstmann RD. (2012) Genome-wide association study indicates two novel resistance loci for severe malaria. Nature, 489, 443-446.
96. Ono K, Wang X, Han J. (2001) Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency. Mol. Cell. Biol., 21, 8276-8288.
97. 2+ mediated cytotoxicity in PC12 cells. J. Neurosci. Res., 64, 661-669.
98. 2+ pump induces apoptosis in vascular smooth muscle cells. Jpn. J. Pharmacol., 90, 164-172.
99. Zylinska L, Kozaczuk A, Szemraj J, Kargas C, Kowalska I. (2007) Functional importance of PMCA isoforms in growth and development of PC12 cells. Ann. N. Y. Acad. Sci., 1099, 254-269.
100. 2+-ATPase 2 in neuronal cells: effects on Ca2+ homeostasis and cell viability. J. Neurochem., 101, 454-465.
101. 2+ stores and triggers apoptosis in insulin-secreting BRIN-BD11 cells. J. Biol. Chem., 285, 30634-30643.
102. 2+ pump (PMCA) in pathologies of mammalian cells. Front. Biosci., 7, d53-84.
103. Roberts-Thomson SJ, Curry MC, Monteith GR. (2010) Plasma membrane calcium pumps and their emerging roles in cancer. World J. Biol. Chem., 1, 248-253.
104. Monteith GR, Davis FM, Roberts-Thomson SJ. (2012) Calcium channels and pumps in cancer: changes and consequences. J. Biol. Chem., 287, 31666-31673.
105. Giacomello M, De Mario A, Scarlatti C, Primerano S, Carafoli E. (2013) Plasma membrane calcium ATPases and related disorders. Int. J. Biochem. Cell Biol., 45, 753-762.
106. 2+ transport. Nature Rev. Cancer, 7, 519-530.
107. Lee WJ, Roberts-Thomson SJ, Monteith GR. (2005) Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines. Biochem. Biophys. Res. Commun., 337, 779-783.
108. 2+-ATPase expression during colon cancer cell line differentiation. Biochem. Biophys. Res. Commun., 355, 932-936.
109. 2+ ATPase expression during colon and gastric cancer cell differentiation. Cell Calcium, 42, 590-605.
110. Aung CS, Ye W, Plowman G, Peters AA, Monteith GR, Roberts-Thomson SJ. (2009) Plasma membrane calcium ATPase 4 and the remodeling of calcium homeostasis in human colon cancer cells. Carcinogenesis, 30, 1962-1969.
111. Rüschoff JH, Brandenburger T, Strehler EE, Filoteo AG, Heinmöller E, Aumüller G, Wilhelm B. (2012) Plasma membrane calcium ATPase expression in human colon multistep carcinogenesis. Cancer Invest., 30, 251-257.
112. Garrahan PJ, Rega AF. (1990) Plasma membrane calcium pump. In: Intracellular Calcium Regulation (ed. F Bronner), pp 271-303. Alan R. Liss.
113. 2+-pump ATPase. Experientia, 39, 311-312.
114. 2+-ATPase from human red cell membranes. Biochim. Biophys. Acta, 600, 796-804.
115. Gatto C, Milanick MA. (1993) Inhibition of the red blood cell calcium pump by eosin and other fluorescein analogues. Am. J. Physiol., 264, C1577-C1586.
116. 2+-transport ATPase and of calmodulin-regulated functions. Biochem. Biophys. Res. Commun., 101, 418-425.
117. 2+ pump ATPase: evidence for direct inhibition by presumed anticalmodulin drugs in the absence of calmodulin. Cell Calcium, 3, 545-559.
118. Borke JL, Minami J, Verma A, Penniston JT, Kumar R. (1987) Monoclonal antibodies to human erythrocyte membrane Ca++-Mg++ adenosine triphosphatase pump recognize an epitope in the basolateral membrane of human kidney distal tubule cells. J. Clin. Invest., 80, 1225-1231.
119. 2+ pump. A monoclonal antibody against the almost inaccessible extracellular face. Biochem. J., 255, 663-670.
120. 2+ pump by a monoclonal antibody. Biochem. J., 264, 87-92.
121. Grover AK. (1988) Monoclonal antibody against an epitope on the cytoplasmic aspect of the plasma membrane calcium pump. J. Biol. Chem., 263, 19510-19512.
122. 2+ pump. J. Biol. Chem., 267, 4097-4101.
123. 2+ pump in rat brain. Patterns of alternative splices seen by isoform-specific antibodies. J. Biol. Chem., 272, 23741-23747.
124. 2+ pump. J. Biol. Chem., 267, 14244-14249.
125. Caride AJ, Filoteo AG, Enyedi A, Verma AK, Penniston JT. (1996) Detection of isoform 4 of the plasma membrane calcium pump in human tissues by using isoform-specific monoclonal antibodies. Biochem. J., 316, 353-359.
126. 2+-ATPase from human plasma membranes. Russ. J. Bioorg. Chem., 25, 448-454.
127. 2+ pumps: Invention and applications of caloxins. World J. Biol. Chem., 2, 39-47.
128. Holmes ME, Chaudhary J, Grover AK. (2003) Mechanism of action of the novel plasma membrane Ca(2+)-pump inhibitor caloxin. Cell Calcium, 33, 241-245.
129. 2+ pump inhibitor. Am. J. Physiol., 280, C1027-C1030.
130. 2+ pump isforoms are inhibited differently by the extracellular inhibitor caloxin 1b1. Am. J. Physiol., 290, C1341-C1349.
131. 2+-pump isoform 4, on coronary artery. J. Cell. Mol. Med., 12, 1049-1060.
132. 2+ in endothelial cells. Cell Calcium, 48, 352-357.
133. Mohamed TMA, Zakeri SA, Baudoin F, Wolf M, Oceandy D, Cartwright EJ, Gul S, Neyses L. (2013) Optimisation and validation of a high throughput screening compatible assay to identify inhibitors of the plasma membrane calcium ATPase pump - a novel therapeutic target for contraception and malaria. J. Pharm. Pharmaceut. Sci., in press (Vol. 16, issue 2, 190-206).
134. Holton ML, Wang W, Emerson M, Neyses L, Armesilla AL. (2010) Plasma membrane calcium ATPase proteins as novel regulators of signal transduction pathways. World J. Biol. Chem., 1, 201-208.
135. 2+ pump anchored by a novel 18-1 motif. J. Biol. Chem., 285, 4015-4024.
136. Tidow H, Poulsen LR, Andreeva A, Knudsen M, Hein KL, Wiuf C, Palmgren MG, Nissen P. (2012) A bimodular mechanism of calcium control in eukaryotes. Nature, 491, 468-472.
137. 2+-ATPase pumps ions across the sarcoplasmic reticulum membrane. Biochim. Biophys. Acta, 1793, 941-946.
138. 2+-ATPase: design of a perfect chemi-osmotic pump. Quart. Rev. Biophys., 43, 501-566.